Cargando…
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer()
Epigenetic changes, including CpG island hypermethylation, occur frequently in bladder cancer (BC) and may be exploited for BC detection and distinction between high-grade (HG) and low-grade (LG) disease. Genome-wide methylation analysis was performed using Agilent Human CpG Island Microarrays to de...
Autores principales: | Olkhov-Mitsel, Ekaterina, Savio, Andrea J., Kron, Ken J., Pethe, Vaijayanti V., Hermanns, Thomas, Fleshner, Neil E., van Rhijn, Bas W., van der Kwast, Theodorus H., Zlotta, Alexandre R., Bapat, Bharati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293735/ https://www.ncbi.nlm.nih.gov/pubmed/28167242 http://dx.doi.org/10.1016/j.tranon.2017.01.001 |
Ejemplares similares
-
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer
por: White-Al Habeeb, Nicole M. A., et al.
Publicado: (2014) -
Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2014) -
Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2012) -
Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis
por: Kamdar, Shivani N., et al.
Publicado: (2016) -
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
por: Kamdar, Shivani, et al.
Publicado: (2019)